Clare Griffin

Institute of Cancer Research

Papers

1

Total Citations

31

H-Index

1

About

Clare Griffin is a leading clinical researcher in radiation oncology, with a primary focus on improving treatment outcomes and quality of life for patients with localised prostate cancer. Her most impactful work includes the landmark PACE-A trial, an international phase 3 randomised controlled trial that directly compared stereotactic body radiotherapy (SBRT) to surgery. This study, cited over 30 times, provided critical randomised evidence in a field long characterised by therapeutic equipoise, demonstrating that SBRT offers superior quality-of-life outcomes for men with early-stage prostate cancer. By rigorously evaluating patient-reported outcomes, Griffin’s research has reshaped clinical decision-making, offering a less invasive alternative to surgery without compromising oncological control. Her contributions are pivotal in advancing evidence-based, patient-centred care in urologic oncology, and her work continues to influence treatment guidelines globally.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.
31 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Institute of Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago